Literature DB >> 3568935

NMR spectrometry. A new method for total stool fat quantification in chronic pancreatitis.

M U Schneider, L Demling, S A Jones, P J Barker, S Domschke, G Heptner, W Domschke.   

Abstract

In the present investigation, suitability of nuclear magnetic resonance (NMR) spectrometry for total stool fat quantification in patients with normal or impaired exocrine pancreatic function (chronic pancreatitis) has been analyzed in comparison with a conventional chloroform-methanol extraction technique. Basic temperature-dependence studies of NMR spectrometry (90 degrees/180 degrees radiofrequency pulse sequence) on 21 chloroform-methanol extracted pure total stool lipid standards (weight range: 0.05-1.6 g) revealed significantly (P less than 0.05) improving correlations between NMR signal amplitudes and corresponding weights at increasing temperatures (r = 0.952/40 degrees C, r = 0.965/60 degrees C, r = 0.988/80 degrees C), thus indicating 80 degrees C as optimal temperature for NMR spectrometric total stool fat quantification. In subsequent comparative measurements of lyophilized stool samples, NMR spectrometry (at 80 degrees C) and conventional chloroform-methanol extraction provided significantly (P less than 0.001) correlated results with respect to total fecal fat contents/day of quantitatively collected and homogenized stools in 93 patients with known exocrine pancreatic function (secretin-pancreozymin test), irrespective of whether correlations were determined for all 93 patients (r = 0.983) or separately for patients with normal (N = 45; r = 0.867), moderately reduced (N = 31; r = 0.946), or highly reduced (N = 17; r = 0.992) exocrine pancreatic function and correspondingly increased total fecal fat excretions.

Entities:  

Mesh:

Year:  1987        PMID: 3568935     DOI: 10.1007/bf01296032

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  A RAPID, RELIABLE PROCEDURE FOR THE DETERMINATION OF TOTAL FECAL LIPIDS, WITH OBSERVATIONS ON THE COMPOSITION OF THE LIPIDS EXCRETED BY HUMAN SUBJECTS IN NORMAL AND PATHOLOGICAL STATES.

Authors:  M A BOWERS; P K LUND; J C MATHIES
Journal:  Clin Chim Acta       Date:  1964-04       Impact factor: 3.786

2.  Correlation of radioactive and chemical fecal fat determinations in various malabsorption syndromes.

Authors:  B D PIMPARKAR; E G TULSKY; W H KALSER; H L BOCKUS
Journal:  Am J Med       Date:  1961-06       Impact factor: 4.965

3.  The effect of dietary fat on fecal fat excretion and subjective symptoms in man.

Authors:  J H ANNEGERS; J H BOUTWELL; A C IVY
Journal:  Gastroenterology       Date:  1948-03       Impact factor: 22.682

4.  The investigation and diagnosis of steatorrhoea.

Authors:  L P R FOURMAN; G HIGGINS
Journal:  Clin Sci       Date:  1948-12       Impact factor: 6.124

5.  Determination of the fat content of meat using nuclear magnetic resonance.

Authors:  J C Casey; C A Miles
Journal:  J Sci Food Agric       Date:  1974-09       Impact factor: 3.638

6.  Reproducibility of the response to secretin and secretin plus pancreozymin in man.

Authors:  F Tympner; S Domschke; W Domschke; M Classen; L Demling
Journal:  Scand J Gastroenterol       Date:  1974       Impact factor: 2.423

7.  An assessment of the Van de Kamer method for estimation of faecal fat.

Authors:  J Kelleher; B E Walker; M S Losowsky
Journal:  Clin Chim Acta       Date:  1970-11       Impact factor: 3.786

8.  Fecal triglycerides. II. Digestive versus absorptive steatorrhea.

Authors:  J B Thompson; C K Su; R E Ringrose; J D Welsh
Journal:  J Lab Clin Med       Date:  1969-03

9.  Chemical faecal fat using single stools.

Authors:  B E Walker; J Kelleher; T Davies; M S Losowsky
Journal:  Scand J Gastroenterol       Date:  1971       Impact factor: 2.423

10.  Fecal fat concentration in patients with steatorrhea.

Authors:  G W Bo-Linn; J S Fordtran
Journal:  Gastroenterology       Date:  1984-08       Impact factor: 22.682

View more
  6 in total

1.  Fat malabsorption in cystic fibrosis: comparison of quantitative fat assay and a novel assay using fecal lauric/behenic acid.

Authors:  Jill Dorsey; Donna Buckley; Suzanne Summer; Ronald J Jandacek; Therese Rider; Patrick Tso; Michael R Narkewicz; James E Heubi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-04       Impact factor: 2.839

2.  Near-infrared spectrometry analysis of fat, neutral sterols, bile acids, and short-chain fatty acids in the feces of patients with pancreatic maldigestion and malabsorption.

Authors:  T Nakamura; T Takeuchi; A Terada; Y Tando; T Suda
Journal:  Int J Pancreatol       Date:  1998-04

3.  Near infrared spectrometry for faecal fat measurement: comparison with conventional gravimetric and titrimetric methods.

Authors:  L Benini; S Caliari; G C Guidi; B Vaona; G Talamini; I Vantini; L A Scuro
Journal:  Gut       Date:  1989-10       Impact factor: 23.059

Review 4.  [Diagnosis and therapy of chronic pancreatitis].

Authors:  R Mahlke; H Lübbers; P G Lankisch
Journal:  Internist (Berl)       Date:  2005-02       Impact factor: 0.743

5.  Determination of fecal fat concentration by near infrared spectrometry for the screening of pancreatic steatorrhea.

Authors:  M Ventrucci; A Cipolla; M Di Stefano; G M Ubalducci; M Middonno; A Ligabue; E Roda
Journal:  Int J Pancreatol       Date:  1998-02

Review 6.  Function tests in the diagnosis of chronic pancreatitis. Critical evaluation.

Authors:  P G Lankisch
Journal:  Int J Pancreatol       Date:  1993-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.